Influenza Vaccines Market By Vaccine Type (Quadrivalent and Trivalent), By Route of administration (Nasal Spray and Injection), By Age-Group ( Pediatric and Adult), Technology (Egg-Based and Cell-Culture) and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI251319 | Publish Date: March 2024 | No. of Pages: 178

Global Influenza Vaccines Market Market Companies

  • GlaxoSmithKline
  • Sanofi
  • FOLIA BIOTECH
  • Genentech
  • Green Cross Moderna Therapeutics
  • Shijiazhuang Yiling Pharmaceutical
  • SK Chemicals
  • UNM Pharma.

Recent News:

  • A UK business named Emergex planned to start producing enough of its all-purpose influenza vaccine in August 2022 to be used in Phase I clinical trials. Emergex asserts that its vaccine is unique from traditional influenza shots in that it primes influenza-specific CD8+ T lymphocytes, which can identify the same peptides when displayed on the surface of infected cells.
  • Abbott introduced the "Influvac Tetra 2022/2023" vaccine in 2022. It gives the host a tiny amount of the flu virus, which aids in the body's induction of immunity.
  • The FDA (Food and Drug Administration) granted Sanofi's licensure request in July 2022 for the Fluzone High Dose Quadrivalent (influenza vaccine), Flublok Quadrivalent (influenza vaccine), and Fluzone Quadrivalent (influenza vaccine) to be used during the 2022–2023 flu season.